Risk factors for bloodstream infection caused by extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime-Reference-Cited by-同舟云学术

Risk factors for bloodstream infection caused by extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime

Published:2015-07 Issue:7 Volume:43 Page:719-723
ISSN:0196-6553
Container-title:American Journal of Infection Control
language:en
Short-container-title:American Journal of Infection Control

Author:

Chopra Teena,Marchaim Dror,Johnson Paul C.,Chalana Indu K.,Tamam Zeinab,Mohammed Mazin,Alkatib Shatha,Tansek Ryan,Chaudhry Khawar,Zhao Jing J.,Pogue Jason M.,Kaye Keith S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Health Policy,Epidemiology

Reference17 articles.

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003;NNNIS System;Am J Infect Control,2003

2. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae;Schwaber;Antimicrobial Agents Chemother,2006

3. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy;Tumbarello;Antimicrobial Agents Chemother,2010

4. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome;Tumbarello;Antimicrobial Agents Chemother,2006

5. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae;Kang;Infect Control Hosp Epidemiol,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia;International Journal of Antimicrobial Agents;2024-08

2. Molecular and bacteriological investigations for the co-existence CRISPR/Cas system and β-lactamases of types extended-spectrum and carbapenemases in Multidrug, extensive drug and Pandrug-Resistant Klebsiella pneumoniae;Saudi Journal of Biological Sciences;2024-07

3. Comparative analysis of a rapid diagnostic test and scoring tools for ESBL detection in Enterobacterales bloodstream infections for optimizing antimicrobial therapy;Microbiology Spectrum;2024-01-11

4. Epidemiology, clinical outcomes and risk factors of third-generation cephalosporin-resistant Escherichia coli hospitalized infections in remote Australia—a case–control study;JAC-Antimicrobial Resistance;2023-11-01

5. Risk Factors for Bloodstream Infections Due to ESBL-Producing Escherichia coli, Klebsiella spp., and Proteus mirabilis;Pharmacy;2023-04-13